{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:06:14Z","timestamp":1779512774624,"version":"3.53.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL150146"],"award-info":[{"award-number":["R01HL150146"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R21HL173848"],"award-info":[{"award-number":["R21HL173848"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.coi.2026.102771","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:15:24Z","timestamp":1775567724000},"page":"102771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u03b22-Glycoprotein I: structure, mechanisms of autoantibody recognition, and polymorphisms"],"prefix":"10.1016","volume":"100","author":[{"given":"Suresh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ponzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2309-7100","authenticated-orcid":false,"given":"Nicola","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102771_bib1","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2026.102771_sbref2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.43258","article-title":"Antiphospholipid syndrome: an antibody-mediated disease with emerging therapeutic opportunities","volume":"77","author":"Newman","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102771_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102771_sbref4","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.2024024469","article-title":"Protection of beta2GPI-deficient mice from thrombosis reflects a defect in PAR3-facilitated platelet activation","volume":"145","author":"Kulkarni","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V96.4.1594","article-title":"Coagulation and fibrinolytic activities in 2 siblings with beta(2)-glycoprotein I deficiency","volume":"96","author":"Takeuchi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib6","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1073\/pnas.81.12.3640","article-title":"Complete amino acid sequence of human plasma beta 2-glycoprotein I","volume":"81","author":"Lozier","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102771_bib7","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1093\/rheumatology\/keac045","article-title":"Carbamylation of beta2-glycoprotein I generates new autoantigens for antiphospholipid syndrome: a new tool for diagnosis of 'seronegative' patients","volume":"61","author":"Capozzi","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102771_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jim.2005.03.016","article-title":"Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies","volume":"300","author":"d'Angeac","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.coi.2026.102771_bib9","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood-2005-03-1201","article-title":"Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response","volume":"106","author":"Buttari","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102675","article-title":"Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: implications for thrombosis risk","volume":"122","author":"Krilis","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2026.102771_bib11","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2009-04-215335","article-title":"Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury","volume":"116","author":"Ioannou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-019-0529-9","article-title":"Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins","volume":"2","author":"Ojha","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/j.coi.2026.102771_bib13","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1074\/jbc.RA118.004767","article-title":"Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces","volume":"293","author":"Osborne","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102771_bib14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.15252\/embj.201593673","article-title":"Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode","volume":"35","author":"Forneris","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2026.102771_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1073\/pnas.1718709115","article-title":"Structure of the C1r-C1s interaction of the C1 complex of complement activation","volume":"115","author":"Almitairi","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102771_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1073\/pnas.1616998114","article-title":"Structure and activation of C1, the complex initiating the classical pathway of the complement cascade","volume":"114","author":"Mortensen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102771_sbref17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood.2024025369","article-title":"Cryo-EM structure of the human native plasma coagulation factor XIII complex","volume":"145","author":"Singh","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib18","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1093\/emboj\/18.19.5166","article-title":"Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure","volume":"18","author":"Bouma","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2026.102771_bib19","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1093\/emboj\/18.22.6228","article-title":"Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome","volume":"18","author":"Schwarzenbacher","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2026.102771_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-2836(02)00621-6","article-title":"Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle X-ray scattering","volume":"321","author":"Hammel","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coi.2026.102771_bib21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","article-title":"Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome","volume":"116","author":"Agar","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib22","doi-asserted-by":"crossref","first-page":"26819","DOI":"10.1039\/C8CP03234C","article-title":"Lysine residues control the conformational dynamics of beta 2-glycoprotein I","volume":"20","author":"Buchholz","year":"2018","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.coi.2026.102771_bib23","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","article-title":"beta(2)-glycoprotein I: a novel component of innate immunity","volume":"117","author":"Agar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib24","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1074\/jbc.RA120.013939","article-title":"The J-elongated conformation of beta(2)-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome","volume":"295","author":"Ruben","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102771_sbref25","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.jtha.2023.07.016","article-title":"Structural analyses of beta(2)-glycoprotein I: is there a circular conformation?","volume":"21","author":"Kumar","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_sbref26","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.2025029488","article-title":"Domain and residue mapping of autoantibodies to beta2GPI reveals differences among antiphospholipid syndrome phenotypes","volume":"146","author":"Kumar","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_sbref27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2024.100041","article-title":"Understanding the structure of beta(2)-glycoprotein I: new insights and future paths for antiphospholipid syndrome","volume":"2","author":"Kumar","year":"2025","journal-title":"Blood Vessel Thromb Hemost"},{"key":"10.1016\/j.coi.2026.102771_bib28","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jtha.2025.02.015","article-title":"Plasmin cleavage of beta2-glycoprotein I alters its structure and ability to bind to pathogenic antibodies","volume":"23","author":"Bradford","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/BJ20050932","article-title":"Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9","volume":"393","author":"Dupuy D\u2032Angeac","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.coi.2026.102771_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0049-3848(98)00047-4","article-title":"A stable, multi-subunit complex of beta2glycoprotein I","volume":"90","author":"Galazka","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.coi.2026.102771_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0049-3848(02)00392-4","article-title":"Polymorphisms beta2-glycoprotein I: phospholipid binding and multimeric structure","volume":"108","author":"Gushiken","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.coi.2026.102771_bib32","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood-2006-10-053199","article-title":"beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation","volume":"110","author":"Hulstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib33","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1073\/pnas.0400281101","article-title":"Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I","volume":"101","author":"Shi","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102771_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jth.12238","article-title":"beta2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions","volume":"11","author":"Pozzi","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib35","article-title":"beta 2-Glicoprotein I (beta 2GpI) is a fibrinogen binding protein","author":"Acquasaliente","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.coi.2026.102771_bib36","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.4049\/jimmunol.161.4.2038","volume":"161","author":"Sheng","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2026.102771_sbref37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100890","article-title":"An allosteric redox switch in domain V of beta(2)-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition","volume":"297","author":"Kumar","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102771_sbref38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41565-018-0336-3","article-title":"Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies","volume":"14","author":"Shaw","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.coi.2026.102771_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46542-y","article-title":"The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial","volume":"15","author":"Hsiehchen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102771_bib40","doi-asserted-by":"crossref","first-page":"29863","DOI":"10.1074\/jbc.M605252200","article-title":"Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells","volume":"281","author":"Luster","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102771_sbref41","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3324\/haematol.2022.281505","article-title":"Plasminogen activator-coated nanobubbles targeting cellbound beta2-glycoprotein I as a novel thrombus-specific thrombolytic strategy","volume":"108","author":"Macor","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2026.102771_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2026.01.027","article-title":"In vivo targeting of open prothrombin with POmAb results in anticoagulation without excessive bleeding","author":"Brake","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1160\/TH17-01-0030","article-title":"Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX\/IXa and X\/Xa, emicizumab, depends on its ability to bridge the antigens","volume":"117","author":"Kitazawa","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib44","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.jtha.2025.07.002","article-title":"Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions","volume":"23","author":"Madrigal","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_sbref45","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.jtha.2024.07.010","article-title":"Atomistic characterization of beta2-glycoprotein I domain V interaction with anionic membranes","volume":"22","author":"Hasdemir","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib46","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jtha.2025.01.020","article-title":"Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo","volume":"23","author":"Heimerl","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan2787","article-title":"Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis","volume":"10","author":"Lauder","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/j.coi.2026.102771_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2025.103071","article-title":"Molecular dynamics simulations of biological membranes and membrane-associated phenomena across scales","volume":"93","author":"Trebesch","year":"2025","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.coi.2026.102771_bib49","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1182\/blood-2010-02-271494","article-title":"Beta 2 glycoprotein I is a substrate of thiol oxidoreductases","volume":"116","author":"Passam","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109714","article-title":"Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps","volume":"255","author":"Kmetova","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2026.102771_bib51","article-title":"Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder","author":"Field","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2026.102771_bib52","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1073\/pnas.90.6.2141","article-title":"Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity","volume":"90","author":"Hunt","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102771_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0037-1614424","article-title":"Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis","volume":"81","author":"Horbach","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib54","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2958.2007.05974.x","article-title":"The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes","volume":"67","author":"Nilsson","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coi.2026.102771_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102771_bib56","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2018.198119","article-title":"New insight into antiphospholipid syndrome: antibodies to beta2glycoprotein I-domain 5 fail to induce thrombi in rats","volume":"104","author":"Durigutto","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2026.102771_bib57","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/art.39187","article-title":"Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against beta2 -glycoprotein i domain 1 and domain 4\/5: ratio of anti-domain 1 to anti-domain 4\/5 as a useful new biomarker for antiphospholipid syndrome","volume":"67","author":"Andreoli","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102771_sbref58","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood.2023022276","article-title":"Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development","volume":"143","author":"Muller-Calleja","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102771_bib59","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jtha.2024.09.036","article-title":"Mechanistic basis of activation and inhibition of protein disulfide isomerase by allosteric antithrombotic compounds","volume":"23","author":"Ponzar","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.str.2009.12.013","article-title":"Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids","volume":"18","author":"Lee","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.coi.2026.102771_bib61","first-page":"452","article-title":"Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I)","volume":"42","author":"Kamboh","year":"1988","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2026.102771_bib62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1529-8817.2004.00097.x","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.coi.2026.102771_bib63","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbapap.2019.03.007","article-title":"Simultaneous characterization of SNPs and N-glycans from multiple glycosylation sites of intact beta-2-glycoprotein-1 (B2GP1) by ESI-qTOF-MS","volume":"1867","author":"Baerenfaenger","year":"2019","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.coi.2026.102771_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004390100549","article-title":"Chimpanzee apolipoprotein H (beta2-glycoprotein I): report on the gene structure, a common polymorphism, and a high prevalence of antiphospholipid antibodies","volume":"109","author":"Sanghera","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2026.102771_bib65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/hmg\/6.2.311","article-title":"Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding","volume":"6","author":"Sanghera","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2026.102771_bib66","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0037-1615360","article-title":"The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma\u2014consequences for the development of anti-beta2-glycoprotein I antibodies","volume":"80","author":"Horbach","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102771_bib67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/art.20741","article-title":"Significance of valine\/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant","volume":"52","author":"Yasuda","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102771_bib68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.humimm.2016.12.008","article-title":"Cellular immune response to beta(2)-glycoprotein-I valine\/leucine(247) phenotypes in Mexican patients with primary antiphospholipid syndrome","volume":"78","author":"Nunez-Alvarez","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.coi.2026.102771_bib69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11596-018-1889-y","article-title":"Thrombophilia caused by beta2-glycoprotein I deficiency: in vitro study of a rare mutation in APOH gene","volume":"38","author":"Zhang","year":"2018","journal-title":"Curr Med Sci"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:22:24Z","timestamp":1779510144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":69,"alternative-id":["S0952791526000488"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102771","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b22-Glycoprotein I: structure, mechanisms of autoantibody recognition, and polymorphisms","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102771"}}